Valuation dashboard for Femasys Inc. (FEMY) with P/E N/A, P/B N/A, EV/EBITDA N/A and dividend yield N/A. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering.
Analysis Summary
Femasys Inc. reported revenue of $2.3M in the most recent fiscal year, growing at a 5-year CAGR of 17.2%.
Balance sheet quality for FEMY: current ratio of 4.5. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| FEMY | Femasys Inc. | $8M | |||
| 0R29.L | Intuitive Surgical, Inc. | $135.9B | 74.05 | 11.86 | 17.8% |
| ISRG | Intuitive Surgical, Inc. | $135.1B | 44.13 | 7.62 | 17.8% |
| 0R19.L | Becton, Dickinson and Company | $52.5B | 33.21 | 2.19 | 6.6% |
| BDX | Becton, Dickinson and Company | $50.1B | 55.54 | 2.08 | 3.8% |
| RMD | ResMed Inc. | $33.1B | 22.81 | 5.23 | 23.9% |
| 0KW4.L | ResMed Inc. | $32.5B | 19.30 | 4.47 | 23.1% |
| MDLN | Medline Inc. | $27.9B | 38.36 | 2.44 | 5.4% |
Price
| Price | $2.54 |
| Market Cap | $8M |
| Exchange | NASDAQ |
| Country | US |
Related companies: AIMD · APLM · BCTX · COCH · CRIS · DARE · EKSO
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of FEMY: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks